GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's other current liabilities for the quarter that ended in Sep. 2014 was $0.66 Mil.
Synageva BioPharma Corp's quarterly other current liabilities declined from Mar. 2014 ($0.65 Mil) to Jun. 2014 ($0.64 Mil) but then increased from Jun. 2014 ($0.64 Mil) to Sep. 2014 ($0.66 Mil).
Synageva BioPharma Corp's annual other current liabilities declined from Dec. 2011 ($0.45 Mil) to Dec. 2012 ($0.00 Mil) and declined from Dec. 2012 ($0.00 Mil) to Dec. 2013 ($-0.00 Mil).
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
|Other Current Liab.||-0.00||0.00||0.00||-0.00||0.00||0.00||0.00||0.45||0.00||-0.00|
Synageva BioPharma Corp Quarterly Data
|Other Current Liab.||-0.00||-0.00||0.00||-0.00||0.00||0.00||-0.00||0.65||0.64||0.66|